T. K. Gerding

The metabolic fate of the dopamine agonist 2-(<i>N</i>-propyl-<i>N</i>-2-thienylethylamino)-5-hydroxytetralin in rats after intravenous and oral administration II. Isolation and identification of metabolites

T. K. Gerding, B. F. H. Drenth, R. A. de Zeeuw et al. · Xenobiotica · 1990 · 23 citations

Medicine, Biochemistry, Pharmacology +11

Glucuronidation of labetalol at the two hydroxy positions by bovine liver microsomes. Isolation, purification, and structure elucidation of the glucuronides of labetalol.

N. R. Niemeijer, T. K. Gerding, Dick de Zeeuw · Drug Metabolism and Disposition · 1991 · 22 citations

Pharmacy, Biochemistry, Pharmacology +13

The metabolic fate of the dopamine agonist 2-(<i>N</i>-propyl-<i>N</i>-2-thienylethylamino)-5-hydroxytetralin in rats after intravenous and oral administration I. Disposition and metabolic profiling

T. K. Gerding, B. F. H. Drenth, H. J. Roosenstein et al. · Xenobiotica · 1990 · 20 citations

Medicine, Pharmacokinetics, Pharmacology +14

Determination of enantiomeric purity of the new D-2 dopamine agonist 2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin (N-0437) by reversed-phase high-performance liquid chromatography after pre-column derivatization with d(+)-glucuronic acid

T. K. Gerding, Ben F. H. Drenth, V. J. M. van de Grampel et al. · Journal of Chromatography B Biomedical Sciences and Applications · 1989 · 18 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Development of a sensitive radioreceptor assay for oxyphenonium in plasma and urine

Kees Ensing, F Kluivingh, T. K. Gerding et al. · Journal of Pharmacy and Pharmacology · 1984 · 17 citations

Medicine, Pharmacokinetics, Pharmacology +13